Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study indicates a potential link between Alzheimer's and common brain disorder

Study indicates a potential link between Alzheimer's and common brain disorder

Researchers elucidate mechanisms underlying spatial memory impairment in Alzheimer's

Researchers elucidate mechanisms underlying spatial memory impairment in Alzheimer's

Antidepressants are not designed for dementia, shows study

Antidepressants are not designed for dementia, shows study

Study elucidates brain circuit mechanism that causes spatial memory impairment in Alzheimer's disease

Study elucidates brain circuit mechanism that causes spatial memory impairment in Alzheimer's disease

Nano and microplastics found in all human organs and tissues

Nano and microplastics found in all human organs and tissues

Diabetes blood markers linked to Alzheimer’s disease pathology, shows study

Diabetes blood markers linked to Alzheimer’s disease pathology, shows study

Identifying Alzheimer’s risk factors in young people

Identifying Alzheimer’s risk factors in young people

Researchers identify new therapeutic target for Alzheimer's disease

Researchers identify new therapeutic target for Alzheimer's disease

Researchers receive funding to develop a model for delivering palliative care in nursing homes

Researchers receive funding to develop a model for delivering palliative care in nursing homes

Using music therapy to combat 'chemobrain'

Using music therapy to combat 'chemobrain'

Reelin inhibition may be effective for treating multiple sclerosis

Reelin inhibition may be effective for treating multiple sclerosis

Researchers develop an integrated technology for seeing into cells at greater detail

Researchers develop an integrated technology for seeing into cells at greater detail

Creating a blood test for the detection of Alzheimer’s disease

Creating a blood test for the detection of Alzheimer’s disease

New techniques help replace malfunctioning microglia associated with neurological disorders

New techniques help replace malfunctioning microglia associated with neurological disorders

Researchers review scientific articles on proteins that help cancer cells enter the brain

Researchers review scientific articles on proteins that help cancer cells enter the brain

Researchers discover a simpler way to diagnose Alzheimer's disease

Researchers discover a simpler way to diagnose Alzheimer's disease

Purdue University startup receives NIH grant to advance Alzheimer's research

Purdue University startup receives NIH grant to advance Alzheimer's research

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

Rice engineers use gene editing to facilitate drug discovery based on natural fungus

Rice engineers use gene editing to facilitate drug discovery based on natural fungus

Highly sensitive dopamine detector can aid in early diagnosis of several disorders

Highly sensitive dopamine detector can aid in early diagnosis of several disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.